Article
A CYP26B1 polymorphism enhances retinoic acid catabolism and may aggravate atherosclerosis.
Molecular medicine (Cambridge, Mass.) - 9 May 2012
Krivospitskaya Olesya, Elmabsout Ali Ateia, Sundman Eva, Söderström Leif A, Ovchinnikova Olga, Gidlöf Andreas C, Scherbak Nikolai, Norata Giuseppe Danilo, Samnegård Ann, Törmä Hans, Abdel-Halim Samy M, Jansson Jan-Håkan, Eriksson Per, Sirsjö Allan, Olofsson Peder S
Abstract excerpt
All-trans retinoic acid, controlled by cytochrome P450, family 26 (CYP26) enzymes, potentially has beneficial effects in atherosclerosis treatment. This study investigates CYP26 subfamily B, polypeptide 1 (CYP26B1) in atherosclerosis and the effects of a genetic polymorphism in CYP26B1 on retinoid catabolism. We found that CYP26B1 mRNA was induced by retinoic acid in human atherosclerotic arteries, and CYP26B1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
